The challenges of screening for at-risk orthopaedic patients addicted to pain management
ROSEMONT, Ill.—The United States makes up less than five percent of the world’s population but consumes 80 percent of the global opioid supply and approximately 99 percent of all hydrocodone—the most commonly prescribed opioid in the world. And, according to the authors of a new literature review in the May issue of The Journal of the American Academy of Orthopaedic Surgeons, orthopaedic surgeons are the third highest prescribers of opioid prescriptions among physicians in the United States—behind primary care physicians and internists.
“The past few decades have seen an alarming rise in opioid use in the United States, and the negative consequences are dramatically increasing,” says study co-author Hassan R. Mir, MD, MBA, associate professor of orthopaedics and rehabilitation at Vanderbilt Orthopaedic Institute. “Management of pain is an important part of patient care; however, the increased usage of opioids for the treatment of pain has led to several unanticipated aftereffects for individual patients and for society at large.”
Opioids are now also prescribed by physicians more frequently to treat chronic conditions, including musculoskeletal pain of the spine and limbs, while prescriptions for non-opioids like nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen have remained constant. The increased usage of opioids for pain management has led to unanticipated consequences:
- Patients building up tolerance to drugs;
- Worse treatment outcomes for conditions including work-related musculoskeletal disorders, joint replacements and spine surgery;
- Unlawful sale or sharing of opioid medications with others; and,
- When used inappropriately, addiction and unintentional overdose deaths can result.
Study co-author Brent J. Morris, MD, a shoulder and elbow surgeon with the Lexington Clinic Orthopedics – Sports Medicine Center, says “Physicians should aim to control pain and improve patient satisfaction while avoiding overprescribing opioids. A comprehensive strategy of risk assessment is needed to identify patients who may be at risk for opioid abuse. Objective measures including patient history, recognition of aberrant behavior, urine drug testing, state prescription drug—monitoring programs, and opioid risk-assessment screening tools may be necessary in select cases.” Reasonable expectations should be established for pain management discussions and follow-up visits, and incorporate a protocol for a patient to be transitioned off of an opioid to acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) at a specific time point following surgery.
According to Drs. Mir and Morris, the patient-physician relationship is built upon trust. Orthopaedic surgeons trust that patients will accurately report their level of pain and only use opioids when appropriate. Patients trust their surgeons to assess and adequately treat the pain associated with their orthopaedic conditions. Unfortunately, a small percentage of patients use opioids non-therapeutically and doctor shop for additional opioids making this a delicate balancing act for physicians.
May 2015 Full JAAOS Table of Contents
- Open Surgical Release for Contractures of the Elbow
- Male and Female Differences Matter in Musculoskeletal Disease
- Medial Epicondylitis: Evaluation and Management
- Infection Prevention in Total Knee Arthroplasty
- Paralytic Ileus in the Orthopaedic Patient
- Replantation of the Upper Extremity: Current Concepts
- Atlantoaxial Rotatory Subluxation in Children
Follow AAOS on Twitter
Follow AAOS on Facebook
Orthopaedic surgeons restore mobility and reduce pain; they help people get back to work and to independent, productive lives. Visit ANationInMotion.org to read successful orthopaedic stories.
More information about the AAOS
Disclosures. From the Lexington Clinic Orthopedics – Sports Medicine, Lexington, KY (Dr. Morris), and the Department of Orthopaedics and Rehabilitation, Vanderbilt University, Nashville, TN (Dr. Mir). Dr. Mir or an immediate family member serves as a paid consultant to Smith & Nephew; serves as a board member, owner, officer, or committee member of AAOS Council on Advocacy, AAOS Diversity Advisory Board, FOT Nominating and Membership Committees and OTA PR Committee. Neither Dr. Morris nor any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article/chapter.